Healthcare -
Biotechnology - NASDAQ - US
$ 83.41
-0.602 %
$ 5.33 B
Market Cap
-78.67
P/E
BPMC - REVENUE
Revenue BPMC - Blueprint Medicines Corporation
509 M
LAST VALUE
57.92%
2 YEAR CAGR
50.22%
5 YEAR CAGR
0.00%
10 YEAR CAGR